Skip to content
Checked.be
Complete company report
Generated 09-08-2026
Active BE 0846.318.862Public limited company

KiOmed Pharma

Rue Haute Claire 4 ·4041 Herstal, Belgium· 14 yrs active
Sector: NACE 72109 (72109)
Conclusion Checked

The computed 12-month bankruptcy probability of KiOmed Pharma is 0.4% (very low). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 14 yrs
Locations 2
Publications 19
Bankruptcy probability (12 mo) Checked model v1 · free
0.4% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Multiple establishment units +Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
Established
Founded in 2012, 14 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 volledig 02-06-2026 2026-00132153
31-12-2024 volledig 20-06-2025 2025-00163632
31-12-2023 volledig 05-06-2024 2024-00115460
31-12-2022 volledig 09-06-2023 2023-00116021
31-12-2021 volledig 22-06-2022 2022-20081190
31-12-2020 volledig 23-07-2021 2021-38500141
31-12-2019 volledig 10-07-2020 2020-30900243
31-12-2018 volledig 25-06-2019 2019-23300316
31-12-2017 volledig 20-06-2018 2018-21700448
31-12-2016 volledig 06-07-2017 2017-27900395
Legal Structure
NACE primary 72109
Legal form Public limited company(014)
Incorporation04-06-2012
StatusActive
Postal code4041
Establishment units 2 locations
KiOmed Pharma S.A.
Rue Haute Claire 4, 4041 HerstalVervaardiging van overige geneesmiddelen, inclusief homeopathische bereidingen
since 20122.230.381.673
KiOmed Pharma
Boulevard de Patience et Beaujonc 3, 4000 LiègeVervaardiging van overige geneesmiddelen, inclusief homeopathische bereidingen
since 20242.378.241.545
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62042B0366/00B003 Wallonia 1.9 ha - -
62071B0791/00G004 Wallonia 4,437 m² 1 · 850 m² 7.2 m · 2 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 29 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
02-06-2026
NBB filing Annual accounts filed
fiscal year 2025 · volledig
2025
25-09-2025
State Gazette act Director changes
v3.2
20-06-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
31-03-2025
State Gazette act Capital & shares
v3.2
16-01-2025
State Gazette act Statutes amendment
v3.2
2024
13-09-2024
State Gazette act Director changes
v3.2
05-06-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
2023
16-08-2023
State Gazette act Director changes
v3.2
09-06-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
01-06-2023
State Gazette act Director changes
v3.2
2022
22-06-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
03-01-2022
State Gazette act Miscellaneous
other · Ariane DENIS
2021
22-09-2021
State Gazette act Director changes
v3.2
23-07-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
09-07-2021
State Gazette act Capital & shares
v3.2
2020
09-10-2020
State Gazette act Director changes
v3.2
10-07-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
10-03-2020
State Gazette act Director changes
v3.2
2019
07-08-2019
State Gazette act Capital & shares
v3.2
25-06-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
28-05-2019
State Gazette act Capital & shares
v3.2
20-05-2019
State Gazette act Capital & shares
v3.2
2018
10-12-2018
State Gazette act Capital & shares
v3.2
20-06-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
2017
25-08-2017
State Gazette act Director changes
v3.2
06-07-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
2016
06-07-2016
State Gazette act Statutes amendment
v3.2
30-05-2016
State Gazette act Director changes
v3.2
2015
18-12-2015
State Gazette act Director changes
v3.2
Belgisch Staatsblad, acts 19 acts
Capital history · 6
31-03-2025
v3.2
09-07-2021
v3.2
07-08-2019
v3.2
28-05-2019
v3.2
20-05-2019
v3.2
10-12-2018
v3.2
All acts · 19 updated 10 months ago
2025
25-09-2025 2 directors appointed Director changes
  • Chagral Invest SRL, Bestuurder
  • Clarentis Sri, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Chagral Invest SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Clarentis Sri",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "Kiomed Pharma"
  }
}
31-03-2025 Capital increase of €6,046,834.90 to €14,726,836.31 Capital & shares
  • €8.680.001,41 → €14.726.836,31
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 14726836.31,
      "delta_eur": 6046834.9,
      "before_eur": 8680001.41,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KiOmed Pharma"
  }
}
16-01-2025 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
2024
13-09-2024 2 directors appointed, 1 resigning Director changes
  • SPARAXIS S.A., Bestuurder
  • Caroline Thielen, Représentant permanent
  • EY Réviseurs d'Entreprises SRL, Commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "SPARAXIS S.A.",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent",
      "person": {
        "rrn": null,
        "name": "Caroline Thielen",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "Kiomed Pharma DIVISION LIEGE"
  }
}
2023
16-08-2023 6 directors appointed Director changes
  • François Blondel, Président exécutif du conseil d'administration
  • Houtaï Choumane, Gedelegeerd bestuurder
  • Caroline Thielen, Bestuurder
  • Benoît Fellin, Bestuurder
  • Marc Nolet, Bestuurder
  • Marie Hobe, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "Pr\u00E9sident ex\u00E9cutif du Conseil d\u0027administration",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois Blondel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "Houta\u00EF Choumane",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Caroline Thielen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Beno\u00EEt Fellin",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marc Nolet",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marie Hobe",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "Kiomed Pharma"
  }
}
01-06-2023 2 directors appointed Director changes
  • Chagral Invest Srl, Bestuurder
  • Samanda S.A., Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Chagral Invest Srl",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Samanda S.A.",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "Kiomed Pharma"
  }
}
2022
03-01-2022 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Ariane DENIS
Summary: otherNotary: Ariane DENIS · LiègeFirm: Yves Godin & Ariane Denis, Notaires Associés SRL
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Ariane DENIS",
    "firm_city": null,
    "firm_name": "Yves Godin \u0026 Ariane Denis, Notaires Associ\u00E9s SRL",
    "office_city": "Li\u00E8ge",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-01-03",
    "filing_date": "2021-12-30",
    "act_kind_objet": "CAPITAL, ACTIONS, DIVERS, STATUTS (TRADUCTION,"
  },
  "decision": {
    "body": "bijzondere_algemene_vergadering",
    "act_date": "2021-12-22",
    "unanimous": null
  },
  "conversion": {
    "effective_date": null,
    "jurisdiction_to": "BE",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "jurisdiction_from": "BE",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0846.318.862",
        "name": "KIOMED PHARMA",
        "role": "other",
        "address": "Rue Haute Claire 4, 4041 Herstal",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:180",
      "7:187",
      "7:188",
      "39, \u00A71"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "La soci\u00E9t\u00E9 a divis\u00E9 ses actions existantes par cent, augmentant ainsi le nombre total d\u0027actions de 89.725 \u00E0 8.972.500. Elle a \u00E9galement \u00E9mis 635.000 nouveaux droits de souscription (\u00AB Warrants SOP 2021 \u00BB) pour financer une future augmentation de capital sous condition suspensive.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Ariane DENIS",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de KiOmed Pharma, tenue le 22 d\u00E9cembre 2021, a d\u00E9cid\u00E9 de diviser chaque action existante par cent, portant le capital \u00E0 8.972.500 actions sans valeur nominale. Elle a \u00E9galement \u00E9mis 635.000 droits de souscription (\u00AB Warrants SOP 2021 \u00BB) et a approuv\u00E9 une augmentation de capital conditionnelle \u00E0 l\u0027exercice de ces droits. Les statuts ont \u00E9t\u00E9 modifi\u00E9s pour refl\u00E9ter ces changements, notamment en ajustant le montant du capital \u00E0 5.350.528,90 \u20AC.",
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal du 22 d\u00E9cembre 2021",
    "les procurations et rapports sp\u00E9ciaux",
    "la coordination des statuts"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}
2021
22-09-2021 2 directors appointed, 1 resigning Director changes
  • Caroline Thielen, Representant permanent
  • EY, Commissaire aux comptes
  • Géry Lefebvre, Representant permanent
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "representant permanent",
      "person": {
        "rrn": null,
        "name": "Caroline Thielen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "representant permanent",
      "person": {
        "rrn": null,
        "name": "G\u00E9ry Lefebvre",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire aux comptes",
      "person": {
        "rrn": null,
        "name": "EY",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "Kiomed Pharma"
  }
}
09-07-2021 Capital increase of €174,000 to €5,350,528.90 Capital & shares
  • €5.176.528,90 → €5.350.528,90
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 5350528.9,
      "delta_eur": 174000.0,
      "before_eur": 5176528.9,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA"
  }
}
2020
09-10-2020 1 director appointed, 1 resigning Director changes
  • Dr Pierre Rigaux, Administrateur indépendant
  • Flexximum R&D srl, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Dr Pierre Rigaux",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Flexximum R\u0026D srl",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "Kiomed Pharma"
  }
}
10-03-2020 3 directors appointed, 2 resigning Director changes
  • Marc Nolet, Bestuurder
  • Benoit Fellin, Représentant permanent
  • Ernst & Young, Commissaire aux comptes
  • Marc Nolet, Bestuurder
  • Françoise Leblanc, Représentant permanent
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marc Nolet",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marc Nolet",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent",
      "person": {
        "rrn": null,
        "name": "Benoit Fellin",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "repr\u00E9sentant permanent",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7oise Leblanc",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire aux comptes",
      "person": {
        "rrn": null,
        "name": "Ernst \u0026 Young",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "Kiomed Pharma"
  }
}
2019
07-08-2019 Capital increase of €985,422.07 to €5,176,528.90 Capital & shares
  • €4.191.106,83 → €5.176.528,90
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 5176528.9,
      "delta_eur": 985422.0700000003,
      "before_eur": 4191106.83,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA"
  }
}
28-05-2019 Capital decrease of €4,313,637.52 to €4,191,106.83 Capital & shares
  • €8.504.744,35 → €4.191.106,83
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 4191106.83,
      "delta_eur": -4313637.52,
      "before_eur": 8504744.35,
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA"
  }
}
20-05-2019 Capital increase of €120 to €8,504,744.35 Capital & shares
  • €8.504.624,35 → €8.504.744,35
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 8504744.35,
      "delta_eur": 120.0,
      "before_eur": 8504624.35,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA"
  }
}
2018
10-12-2018 Transaction in capital or shares Capital & shares
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA"
  }
}
2017
25-08-2017 Marie-Laure Moreau appointed as commissaire Director changes
  • Marie-Laure Moreau, Commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Marie-Laure Moreau",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOmed Pharma"
  }
}
2016
06-07-2016 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOMED PHARMA"
  },
  "legal_form_change": {
    "new": "soci\u00E9t\u00E9 anonyme",
    "old": "soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
30-05-2016 1 director appointed, 1 resigning Director changes
  • INNODE SA, Bestuurder
  • François BLONDEL, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois BLONDEL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "INNODE SA",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "KIOmed Pharma"
  }
}
2015
18-12-2015 3 directors appointed Director changes
  • KiOmed Pharma, Commis
  • S.C.R.L. ERNST & YOUNG REVISEURS D'ENTREPRISE, Auditor
  • Monsieur Philippe Pire, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commis",
      "person": {
        "rrn": null,
        "name": "KiOmed Pharma",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "S.C.R.L. ERNST \u0026 YOUNG REVISEURS D\u0027ENTREPRISE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Monsieur Philippe Pire",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0846.318.862",
    "name_full": "SYNOLYNE PHARMA"
  }
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE) Crossroads Bank
Activities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190Niet-gespecialiseerde groothandel46900Niet-gespecialiseerde groothandel46900
Primary activity highlighted.
Names & trade names
Legal nameFR KiOmed Pharma
Registered office
Rue Haute Claire 4
4041 Herstal, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
Advanced Coatings & Construction Solutions BE 0434.800.025 · Liège
MITHRA Recherche et Développement BE 0534.909.666 · Liège
AARDEX Group BE 0631.773.965 · Seraing
aeco BE 0473.740.377 · Raeren
AGRA-OST BE 0430.229.345 · Sankt Vith
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative